97 related articles for article (PubMed ID: 14533042)
1. [Hemobahn-endoprosthesis: long-term experience (< or = 4 years follow-up) with percutaneous application in stenoses and occlusions of the superficial femoral artery].
Fischer M; Langhoff R; Schulte KL
Zentralbl Chir; 2003 Sep; 128(9):740-5. PubMed ID: 14533042
[TBL] [Abstract][Full Text] [Related]
2. [Hemobahn endoprosthesis: experience with percutaneous placing in the arteria femoralis superficialis].
Fischer M; Sakriss U; Stalke J; Schulte KL
Zentralbl Chir; 2001 Feb; 126(2):138-43. PubMed ID: 11253539
[TBL] [Abstract][Full Text] [Related]
3. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience.
Fischer M; Schwabe C; Schulte KL
J Endovasc Ther; 2006 Jun; 13(3):281-90. PubMed ID: 16784314
[TBL] [Abstract][Full Text] [Related]
4. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial.
Jahnke T; Andresen R; Müller-Hülsbeck S; Schäfer FK; Voshage G; Heller M; Brossmann J
J Vasc Interv Radiol; 2003 Jan; 14(1):41-51. PubMed ID: 12525585
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with the OptiMed sinus stent in the peripheral arteries.
Henry M; Henry I; Klonaris C; Hugel M
J Endovasc Ther; 2003 Aug; 10(4):772-9. PubMed ID: 14533964
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up after implantation of the EverFlex nitinol stent in long lesions of the superficial femoral artery.
Ruef J
Angiology; 2009; 60(1):31-5. PubMed ID: 18508851
[TBL] [Abstract][Full Text] [Related]
7. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study.
Wiesinger B; Beregi JP; Oliva VL; Dietrich T; Tepe G; Bosiers M; Hüttl K; Müller-Hülsbeck S; Bray A; Tielemans H; Duda SH
J Endovasc Ther; 2005 Apr; 12(2):240-6. PubMed ID: 15823072
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft.
Bray PJ; Robson WJ; Bray AE
J Endovasc Ther; 2003 Jun; 10(3):619-28. PubMed ID: 12932177
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial.
Saxon RR; Coffman JM; Gooding JM; Natuzzi E; Ponec DJ
J Vasc Interv Radiol; 2003 Mar; 14(3):303-11. PubMed ID: 12631634
[TBL] [Abstract][Full Text] [Related]
10. Hemobahn stent-grafts in the treatment of femoropopliteal occlusive disease.
Daenens K; Maleux G; Fourneau I; Nevelsteen A
J Cardiovasc Surg (Torino); 2005 Feb; 46(1):25-9. PubMed ID: 15758873
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
Kudo T; Chandra FA; Ahn SS
J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
[TBL] [Abstract][Full Text] [Related]
12. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease.
Saxon RR; Dake MD; Volgelzang RL; Katzen BT; Becker GJ
J Vasc Interv Radiol; 2008 Jun; 19(6):823-32. PubMed ID: 18503895
[TBL] [Abstract][Full Text] [Related]
13. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
[TBL] [Abstract][Full Text] [Related]
14. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM
J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
[TBL] [Abstract][Full Text] [Related]
15. Femoropopliteal bypass vs percutaneous transluminal angioplasty and stenting in treatment of peripheral artery diseases of infrainquinal segment - short-term results.
Cvetanovski MV; Jovev S; Cvetanovska M; Blazevski B; Colanceski R; Andreevska T; Gramatnikovski N; Kartalov A
Prilozi; 2009 Jul; 30(1):105-18. PubMed ID: 19736534
[TBL] [Abstract][Full Text] [Related]
16. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?
Alimi YS; Hakam Z; Hartung O; Boufi M; Barthèlemy P; Aissi K; Dubuc M
Eur J Vasc Endovasc Surg; 2008 Mar; 35(3):346-52. PubMed ID: 17983772
[TBL] [Abstract][Full Text] [Related]
19. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis.
Doomernik DE; Golchehr B; Lensvelt MM; Reijnen MM
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):447-57. PubMed ID: 22854524
[TBL] [Abstract][Full Text] [Related]
20. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease.
Bauermeister G
J Endovasc Ther; 2001 Jun; 8(3):315-20. PubMed ID: 11491267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
